Orthofix Medical Inc (OFIX) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Orthofix Medical Inc   (NASDAQ: OFIX)

Select the Financial Report: Select the Period:


Description of Orthofix Medical Inc's Business Segments


Orthofix Medical Inc. is a prominent player in the medical devices sector, particularly focusing on orthopedic solutions. The companys offerings are extensive and can be categorized into several key segments, each providing tailored products and services to address various orthopedic needs. Below is a comprehensive overview of the segments, products, and services that Orthofix Medical Inc. offers:

1. Spine Fixation
Orthofix specializes in a diverse range of spine fixation products aimed at providing stability and support to the spine. Key offerings include:
- Spine Fusion Devices: These devices are designed to facilitate the fusion of vertebrae to treat conditions like degenerative disc disease, scoliosis, or spinal trauma. They enhance stability and promote healing.
- Cervical Plates: These are used in cervical spine surgeries to provide fixation and support across the cervical vertebrae, enabling alignment and healing post-surgery.
- Pedicle Screw Systems: Designed to secure the spine during surgical corrections, these systems improve spinal alignment and stability by securely anchoring to the pedicles of vertebrae.

Biologics
Orthofix’s biologics segment focuses on promoting natural healing through innovative solutions. Major products include:
- Bone Graft Substitutes: These are used in lieu of traditional bone grafts to facilitate the healing of bone defects and fractures. They often support osteoconductive, osteoinductive, or osteogenic properties critical for bone regeneration.
- Tissue Repair Products: These assist in the regeneration of soft tissues and are essential in orthopedic surgeries, promoting healing and recovery of injured areas.

Sports Medicine
Orthofix offers specialized products aimed at the recovery and rehabilitation of athletes and active individuals. This segment includes:
- Soft Tissue Repair Devices: These devices aid in repairing and reconstructing torn or damaged soft tissues, often essential in sports-related injuries.
- Arthroscopy Systems: Advanced tools and instruments used in minimally invasive surgeries to diagnose and treat joint problems. They enable quicker recovery times and reduced scarring.
- Joint Reconstruction Products: Specifically designed for procedures that restore function and stability to damaged joints, allowing athletes to return to their activity more rapidly.

Extremities
This segment addresses a variety of products designed for the upper and lower extremities:
- Upper and Lower Extremity Fixation Devices: These include plates, screws, and pins specifically designed for the stabilization of fractures in the arms and legs.
- Foot and Ankle Implants: Orthofix provides specialized implants that are used in surgeries to correct issues within the foot and ankle, enhancing mobility and function.
- External Fixation Systems: These are used for the stabilization of fractures and for limb lengthening procedures, allowing for alignment and healing without the need for invasive internal hardware.

OrthoRehab
The OrthoRehab segment includes products that facilitate recovery post-injury or surgery:
- Bone Growth Stimulators: These devices utilize electromagnetic fields or ultrasound to promote the healing of fractures, particularly in cases where healing is slower than expected.
- Bracing Systems: Orthofix offers various bracing products designed to support the injured area and prevent further injury during the recovery process.

Additional Services
Beyond product offerings, Orthofix also provides various services that support healthcare providers and patients:
- Clinical Education and Training: Orthofix offers educational programs to healthcare providers, ensuring they are well-informed on product use, surgical techniques, and patient care.
- Reimbursement Support: The company assists healthcare providers with navigating the complexities of insurance reimbursement processes related to their products.
- Clinical Research and Development: Orthofix engages in ongoing research to innovate and enhance their product offerings, ensuring they meet the evolving needs of the market.
- Regulatory Compliance Support: The company helps its clients understand and adhere to regulatory requirements, ensuring products and services meet industry standards.

Conclusion
Orthofix Medical Inc. stands out in the orthopedic market with their comprehensive range of products and services that cater to the diverse needs of patients suffering from orthopedic conditions. Through a commitment to innovation and quality, the company ensures that healthcare providers are equipped with the tools necessary for effective patient care, enhancing recovery and improving quality of life for individuals dealing with musculoskeletal injuries and conditions.


Composition of Orthofix Medical Inc Revenues by Segments

 
Therapeutic Solutions    29.39 % of total Revenue
Spinal Implants Biologics and Enabling Technologies    53.97 % of total Revenue
Global Spine    83.37 % of total Revenue
Global Limb Reconstruction    16.72 % of total Revenue
U S    82.08 % of total Revenue
U S Global Spine    77.55 % of total Revenue
U S Global Limb Reconstruction    4.53 % of total Revenue
International    18 % of total Revenue
International Global Spine    5.82 % of total Revenue
International Global Limb Reconstruction    12.18 % of total Revenue
Italy    3 % of total Revenue
France    1.34 % of total Revenue
United Kingdom    1.97 % of total Revenue
Germany    1.1 % of total Revenue
Brazil    0.53 % of total Revenue
Others    10.06 % of total Revenue

Q1 three months ended (Mar 31 2026)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
Therapeutic Solutions 57.77 29.39 %
Spinal Implants Biologics and Enabling Technologies 106.08 53.97 %
Global Spine 163.85 83.37 %
Global Limb Reconstruction 32.86 16.72 %
U S 161.33 82.08 %
U S Global Spine 152.42 77.55 %
U S Global Limb Reconstruction 8.91 4.53 %
International 35.38 18 %
International Global Spine 11.44 5.82 %
International Global Limb Reconstruction 23.95 12.18 %
Italy 5.90 3 %
France 2.63 1.34 %
United Kingdom 3.87 1.97 %
Germany 2.17 1.1 %
Brazil 1.03 0.53 %
Others 19.77 10.06 %
Total 196.55 100 %




Q1 three months ended (Mar 31 2026)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
Therapeutic Solutions 4.95 % -
Spinal Implants Biologics and Enabling Technologies -2.49 % -
Global Spine 0.01 % -
Global Limb Reconstruction 10.22 % -
U S -0.22 % -
U S Global Spine -0.19 % -
U S Global Limb Reconstruction -0.75 % -
International 10.68 % -
International Global Spine 2.71 % -
International Global Limb Reconstruction 14.94 % -
Italy 16.82 % -
France 0.27 % -
United Kingdom 27.53 % -
Germany -1.72 % -
Brazil -8.9 % -
Others 10.39 % -
Total 1.51 % -76.09 %




Q1 three months ended (Mar 31 2026)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Total -20.91 -




Q1 three months ended (Mar 31 2026)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Total - -




Annual Report on Orthofix Medical Inc Divisions, Sales by Country

 
Spinal Implants Biologics and Enabling Technologies   Spinal Implants Biologics and Enabling Technologies Segment contribution to total sales 53.59 % of total Revenue
Global Spine   Global Spine Segment contribution to total sales 83.65 % of total Revenue
Global Limb Reconstruction   Global Limb Reconstruction Segment contribution to total sales 16.38 % of total Revenue
U S   U S Segment contribution to total sales 83.22 % of total Revenue
U S Global Spine   U S Global Spine Segment contribution to total sales 78.48 % of total Revenue
U S Global Limb Reconstruction   U S Global Limb Reconstruction Segment contribution to total sales 4.74 % of total Revenue
International   International Segment contribution to total sales 16.82 % of total Revenue
International Global Spine   International Global Spine Segment contribution to total sales 5.17 % of total Revenue
International Global Limb Reconstruction   International Global Limb Reconstruction Segment contribution to total sales 11.65 % of total Revenue
Italy   Italy Segment contribution to total sales 2.71 % of total Revenue
France   France Segment contribution to total sales 1.45 % of total Revenue
United Kingdom   United Kingdom Segment contribution to total sales 1.62 % of total Revenue
Germany   Germany Segment contribution to total sales 1.11 % of total Revenue
Brazil   Brazil Segment contribution to total sales 0.59 % of total Revenue
Others   Others Segment contribution to total sales 9.33 % of total Revenue
Bone Growth Therapies   Bone Growth Therapies Segment contribution to total sales 30.07 % of total Revenue


Twelve months ended 2025
OFIX s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
Spinal Implants Biologics and Enabling Technologies 440.49 53.59 %
Global Spine 687.66 83.65 %
Global Limb Reconstruction 134.66 16.38 %
U S 684.07 83.22 %
U S Global Spine 645.14 78.48 %
U S Global Limb Reconstruction 38.93 4.74 %
International 138.25 16.82 %
International Global Spine 42.52 5.17 %
International Global Limb Reconstruction 95.73 11.65 %
Italy 22.28 2.71 %
France 11.96 1.45 %
United Kingdom 13.33 1.62 %
Germany 9.11 1.11 %
Brazil 4.84 0.59 %
Others 76.73 9.33 %
Total 822.02 100 %
Bone Growth Therapies 247.16 30.07 %


Twelve months ended 2025
OFIX s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Total -92.19 -

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Spinal Implants Biologics and Enabling Technologies -0.32 % -
Global Spine 1.83 % -
Global Limb Reconstruction 8.44 % -
U S 1.67 % -
U S Global Spine 0.93 % -
U S Global Limb Reconstruction 15.79 % -
International 9.13 % -
International Global Spine 17.71 % -
International Global Limb Reconstruction 5.71 % -
Italy 6.08 % -
France -10.65 % -
United Kingdom 19.23 % -
Germany 1.14 % -
Brazil -15.26 % -
Others 15.57 % -
Total 2.9 % -
Bone Growth Therapies 5.89 % -
Global Orthopedics - -
U S Global Orthopedics - -
International Global Orthopedics - -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.